Trio Moderna Pluss SIA is based in Latvia. The head office is in Riga. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was first established on July 03, 2002. The total number of employees is currently 8 (2023). The latest financial highlights indicate a net sales revenue increase of 10.2% in 2024. A negative growth of 6.55% was recorded in its total assets. Trio Moderna Pluss SIA’s net profit margin increased by 2.98% in 2024.

Headquarters
Dambja iela 5
Riga; Riga; Postal Code: 1005

Contact Details: Purchase the Trio Moderna Pluss SIA report to view the information.

Basic Information

Total Employees:

Purchase the Trio Moderna Pluss SIA report to view the information.

Registered Capital:

Purchase the Trio Moderna Pluss SIA report to view the information.

Financial Auditors:

Purchase the Trio Moderna Pluss SIA report to view the information.

Incorporation Date:

July 03, 2002

Key Executives

Purchase this report to view the information.

Member of Management Board

Ownership Details

Purchase this report to view the information.

100%

Company Performance

Financial values in the chart are available after Trio Moderna Pluss SIA report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.

Net sales revenue

10.2%▲

Total operating revenue

10.31%▲

Operating Profit/Loss (EBIT)

21.03%▲

EBITDA

21.03%▲

Net Profit/Loss for the Period

21.03%▲

Total Assets

-6.55%▼

Total Equity

-15.01%▼

Operating Profit Margin (ROS)

2.98%▲

Net Profit Margin

2.98%▲

Return on Equity (ROE)

1.36%▲

Quick Ratio

-0.38%▼

Cash Ratio

0.04%▲

Trio Moderna Pluss SIA (Latvia)